In a recent shareholder meeting held on Thursday, Henry Schein Inc. (NASDAQ:HSIC), a prominent player in the Healthcare Providers & Services industry with a market capitalization of $8.7 billion and an "GOOD" InvestingPro Financial Health score, announced the approval of key proposals, including the election of directors and executive compensation. The meeting, which took place on May 22, 2025, saw the re-election of twelve directors who will serve until 2026. Additionally, Max Lin and William K. "Dan" Daniel were elected as new directors under the same term, following the satisfaction of certain conditions.
Shareholders also cast their votes on the "say-on-pay" proposal, which involves a non-binding approval of the compensation paid to the company’s named executive officers in 2024. The proposal passed with a majority of votes in favor.
Furthermore, the appointment of BDO USA, P.C. as Henry Schein’s independent registered public accounting firm for the fiscal year ending December 27, 2025, was ratified.
The detailed voting results for each director and proposal were disclosed, providing transparency regarding the level of support for the company’s governance and executive compensation practices.
This information, based on a press release statement, reflects the decisions made by Henry Schein’s stakeholders and outlines the company’s leadership structure for the upcoming year. The outcomes of the votes indicate shareholder confidence in the company’s strategic direction and governance.
In other recent news, Henry Schein reported its first-quarter 2025 earnings, with earnings per share (EPS) of $1.15 surpassing analysts’ forecast of $1.12, although revenue fell short at $3.17 billion against the expected $3.24 billion. Despite the revenue miss, the company’s non-GAAP operating margin improved by 14 basis points to 7.25%, and its restructuring efforts achieved $60 million in cost savings. Additionally, Henry Schein announced a significant $250 million investment from KKR, resulting in KKR acquiring a 12% stake in the company. This strategic move also brought two new independent directors to Henry Schein’s Board, enhancing its governance structure. The company remains optimistic about future growth, aiming for mid-single-digit growth in adjusted EBITDA and expecting high-growth businesses to contribute significantly to operating income by 2027. Meanwhile, analysts from firms such as Stifel and Piper Sandler have shown interest in the company’s tariff mitigation strategies and its ability to manage foreign exchange volatility. Henry Schein’s leadership continues to focus on strategic initiatives and product innovations to drive future growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.